St. Francis Hospital

New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men

Retrieved on: 
Thursday, November 9, 2023
Yale School of Medicine, CAD, IV, Treatment, Coronary artery disease, Dissection, Doctor of Philosophy, IVL, Journal, St. Francis Hospital, TLF, MACE, HR, Perforation, CT, Woman, Safety, Society, USE, Hospital, Reflow soldering, EMPOWER, Cardiovascular disease, Pharmaceutical industry, Birth control, MD, Cardiology

The one-year results from Disrupt CAD III and IV trials were recently published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) .

Key Points: 
  • The one-year results from Disrupt CAD III and IV trials were recently published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) .
  • In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety and effectiveness in women and men at a one-year follow-up.
  • At one-year, major adverse cardiovascular event (MACE) rates were not different between women and men (12.3% vs 13.2%, p=0.52) and there was no difference between women and men in target lesion failure (TLF, 10.4% vs. 11.2% p=0.43).
  • The European lead is Nieves Gonzalo, MD, PhD, Consultant Interventional Cardiologist at Hospital Clinico San Carlos in Madrid, Spain.

Shockwave Medical Introduces Enhanced Coronary IVL Catheter in the United States

Retrieved on: 
Friday, October 20, 2023
Food, C2, MD, Shock wave, IVL, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Level 2, St. Francis Hospital, Workflow, TCT, Calcium, Cardiovascular disease, Medical imaging

SANTA CLARA, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today the planned U.S. introduction of the Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) catheter following approval by the U.S. Food and Drug Administration. The Shockwave C2+ catheter provides 50 percent more pulses per catheter than the Shockwave C2 catheter that was approved in the U.S. in 2021. The enhanced C2+ catheter will make its U.S. debut at the 35th Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium of the Cardiovascular Research Foundation, with the full commercial launch planned for the beginning of November.

Key Points: 
  • SANTA CLARA, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today the planned U.S. introduction of the Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) catheter following approval by the U.S. Food and Drug Administration.
  • The Shockwave C2+ catheter provides 50 percent more pulses per catheter than the Shockwave C2 catheter that was approved in the U.S. in 2021.
  • The enhanced C2+ catheter will make its U.S. debut at the 35th Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium of the Cardiovascular Research Foundation, with the full commercial launch planned for the beginning of November.
  • “The enhancements of Shockwave C2+ will be an added benefit of IVL for optimally treating complex calcium, including more diffuse disease, as well as nodular and thick, eccentric calcium,” said Richard Shlofmitz, MD, Chairman, Department of Cardiology, St. Francis Hospital in Roslyn, New York, who performed the first U.S. commercial case with Shockwave C2+.

Results from Magenta Medical's US Early Feasibility Study of the World's Smallest and Most Powerful Heart Pump to be Highlighted at TCT 2023

Retrieved on: 
Tuesday, October 10, 2023
Coronary artery disease, Mount Sinai Hospital (Manhattan), Percutaneous coronary intervention, Safety, Hospital, Teaching hospital, Diagnosis, Cardiology, Mount Sinai Hospital, Magenta, Ventricular assist device, Interventional cardiology, Philippine Heart Center, North Shore University Hospital, St. Francis Hospital, TCT, Patient, Pharmaceutical industry, Medical device

KADIMA, Israel , Oct. 10, 2023 /PRNewswire/ --Results from Magenta Medical's Early Feasibility Study of the Elevate™ System, for the high-risk percutaneous coronary intervention (HR-PCI) indication, will be announced in an oral presentation at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation in San Francisco. Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).

Key Points: 
  • Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).
  • Presentation title: Magenta Elevate™: First US Experience with High-Output, Low-French Size Percutaneous Mechanical Circulatory Support
    Session: TCT Innovation V: Innovation in Coronary Disease Diagnosis and Therapies/Featured Technological Trends: Percutaneous Mechanical Circulatory Support.
  • Magenta's US Early Feasibility Study was initiated to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures.
  • Fifteen patients were treated in the study at the Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital.

SpectraWAVE Secures 510(k) Clearance to Add Saline Imaging and Expanded Artificial Intelligence Features to the HyperVue™ Imaging System

Retrieved on: 
Tuesday, September 19, 2023
Technology, Medical Devices, Medical Supplies, FDA, Health Technology, Cardiology, Hardware, Health, Artificial Intelligence, Plaque, Blood vessel, Myocardial infarction, EEL, Fractional flow reserve, Food and Drug Administration, NIRS, CAD, Nasiriyah Heart Center, Intelligence, Multimedia, Angiography, Meta-analysis, Calcium, Congress, Acquisition, Patient, Physician, Risk, Algorithm, Artificial intelligence, St. Francis Hospital, Coronary artery disease, European Society of Cardiology, Arrest, Food, Medical imaging

The intravascular imaging system combines next-generation DeepOCT™ images and near infrared spectroscopy (NIRS) with state-of-the-art ease of use to support physicians optimizing coronary stenting in the cardiac catheterization lab.

Key Points: 
  • The intravascular imaging system combines next-generation DeepOCT™ images and near infrared spectroscopy (NIRS) with state-of-the-art ease of use to support physicians optimizing coronary stenting in the cardiac catheterization lab.
  • Newly cleared product enhancements include contrast-free saline imaging, artificial intelligence algorithms to support the identification of key clinical structures of calcium and external elastic lamina (EEL), and hands-free angiographic co-registration.
  • The latest clearance adds to the existing HyperVue toolkit , which includes artificial intelligence enabled lipid, lumen, stent, and sidebranch detection, as well as the no-flush prep Starlight™ Imaging Catheter designed for efficient setup and image acquisition in complex lesions.
  • Next generation DeepOCT and Near Infrared Spectroscopy intravascular imaging system now includes compatibility with contrast-free saline imaging, advanced artificial intelligence algorithms to identify calcium and external elastic lamina, and hands-free angiographic co-registration.

ENT Partners Opens 20th clinic location

Retrieved on: 
Tuesday, August 29, 2023
ENT, Patient, Partnership, St. Joseph's Hospital, Ear, Allergy, Hearing loss, Sleep, Mary, mother of Jesus, Doctor of Audiology, TK, Nose, Suite, Audiology, St. Francis Hospital, Diagnosis, Hospital, Saint Mary's Hospital, Health, Ascension, Nursing, Chicago metropolitan area, MD

MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- ENT Partners, LLC , a leading Physician Practice Management Company (PPMC) announced that Chicago ENT one of the largest ear, nose, and throat practices in Illinois, and part of the ENT Partners family of practices has opened its newest practice location at Ascension Saint Joseph Hospital in the Lakeview area of Chicago on August 29, 2023.

Key Points: 
  • MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- ENT Partners, LLC , a leading Physician Practice Management Company (PPMC) announced that Chicago ENT one of the largest ear, nose, and throat practices in Illinois, and part of the ENT Partners family of practices has opened its newest practice location at Ascension Saint Joseph Hospital in the Lakeview area of Chicago on August 29, 2023.
  • "We are delighted to announce the opening of our sixth office, where we proudly offer ENT services tailored to our patients' needs.
  • "Expanding our footprint and health-system relationships across the Chicagoland area is a great step for ENT Partners," said Jim Feinstein CEO of ENT Partners.
  • Patients may schedule appointments at Chicago ENT - Lakeview through their website, ChicagoENT.com , or by calling 773.296.5500.

Magenta Medical Completes Enrollment to Early Feasibility Study for World's Smallest Heart Pump

Retrieved on: 
Tuesday, August 22, 2023
Heart, Abdominal aortic aneurysm, Cardiogenic shock, Interventional cardiology, Aneurysm, Cardiac catheterization, Northwell Health, Splenic infarction, Quality of life, Nasiriyah Heart Center, Magenta, Artery, Federal, IVUS, Atherosclerosis, Teaching hospital, PCI, North Shore University Hospital, LAD, Mount Sinai Hospital, Patient, Risk, Elevate, St. Francis Hospital, Hospital, Coronary artery disease, FDA, Mount Sinai Health System, Groin, Safety, Pharmaceutical industry, Medical device, Nursing, Cardiology

KADIMA, Israel, Aug. 22, 2023 /PRNewswire/ -- Magenta Medical, developer of the world's smallest heart pump, announced today the completion of enrollment to its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication. All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital. The Elevate™ Early Feasibility Study was approved by the FDA to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures, and constitutes the first step in a clinical program intended to secure approval for the device in the US for this indication.

Key Points: 
  • KADIMA, Israel, Aug. 22, 2023 /PRNewswire/ -- Magenta Medical , developer of the world's smallest heart pump, announced today the completion of enrollment to its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication.
  • All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital.
  • "Having now used the system in nine complex, high-risk PCI cases, I can truly appreciate its advantages," said Dr. Sharma.
  • The percutaneous Elevate™ heart pump is inserted over a guidewire through commercially available 10 Fr introducer sheaths that require a small puncture in the groin.

Two Washington Hospitals Recognized Among America's Best Maternity Hospitals

Retrieved on: 
Wednesday, June 14, 2023
Patient satisfaction, St. Elizabeth Hospital, Statistics, Saint Francis Hospital & Medical Center, FACOG, BSN, Creativity, Saint Elizabeth, Hypertension, Hospital, St. Francis, MD, Patient, Health facility, Federal Way, Washington, Internal bleeding, St. Francis Hospital, Empathy, RNC, Safety, Nursing, Newsweek

SEATTLE and TACOMA, Wash., June 14, 2023 /PRNewswire/ -- Family birth teams at St. Elizabeth Hospital (Enumclaw, WA) and St. Francis Hospital (Federal Way, WA), were named among Newsweek's list of America's Best Maternity Hospitals 2023. Both hospitals are proud members of the Virginia Mason Franciscan Health system and serve patients outside of the metro area expanding critical access to many surrounding communities.

Key Points: 
  • Newsweek's evaluation is based on a nationwide online survey of hospital managers and maternity healthcare professionals; key performance indicators surrounding maternity care; and patient satisfaction data.
  • Both Virginia Mason Franciscan Health facilities received four ribbons from Newsweek, the second-highest honor given by the organizers.
  • This is the fourth consecutive year that St. Francis Hospital has been recognized, and the third consecutive year St. Elizabeth has been recognized.
  • When patients are here at Saint Francis, we strive to ensure it is the best experience that they can get.

First Patients Treated in the US with the World's Smallest Heart Pump

Retrieved on: 
Wednesday, June 7, 2023
Heart, Cardiogenic shock, Interventional cardiology, Instability, Perfusion, Catheter, Splenic infarction, Nasiriyah Heart Center, Magenta, Artery, Federal, Cardiology, PCI, Patient, Risk, St. Francis Hospital, Hospital, Coronary artery disease, FDA, Mount Sinai Health System, Groin, Weaning, Safety, Disease, Pharmaceutical industry, Medical device, Nursing

KADIMA, Israel, June 7, 2023 /PRNewswire/ -- Magenta Medical, developer of the world's smallest heart pump, announced today the initiation of its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication. The study began with the treatment of two patients: one in Mount Sinai Health System and one in St. Francis Hospital and Heart Center, both in New York.

Key Points: 
  • The study began with the treatment of two patients: one in Mount Sinai Health System and one in St. Francis Hospital and Heart Center, both in New York.
  • Some of these patients present with more severe disease, making them prone to instability during coronary intervention, and are thus categorized as high-risk.
  • In these patients, it is advantageous to provide mechanical circulatory support during the procedure to preserve systemic blood pressure and maintain perfusion of vital organs, including the heart itself.
  • The percutaneous Elevate™ heart pump is inserted over a guidewire through commercially available 10 Fr introducer sheaths that require a small puncture in the groin.

Dr. Praveena Paruchuri, MD joins Auburn Heart Institute

Retrieved on: 
Monday, June 5, 2023
Ventricular septal defect, CTS, Cardiovascular disease, University School, Auburn Community Hospital, Research, Multimedia, NYU Langone Hospital – Long Island, Temple University School of Medicine, Winthrop University, Medical director, Patient, TEE, Internal medicine, AHI, St. Francis Hospital, Hospital, Cardiology, Transesophageal echocardiogram, Society of Cardiovascular Computed Tomography, Medical imaging, Medical device, West Indies, Auburn, MD, Medicine

"I am excited to join a growing cardiology practice at Auburn Community Hospital and to be able to practice in the Auburn community and be a part of building the Auburn Heart Institute," stated Praveena Paruchuri, MD.

Key Points: 
  • "I am excited to join a growing cardiology practice at Auburn Community Hospital and to be able to practice in the Auburn community and be a part of building the Auburn Heart Institute," stated Praveena Paruchuri, MD.
  • "We are thrilled to have Dr. Paruchuri join the Auburn Heart Institute.
  • By securing Dr. Paruchuri's services, we are well on our way to achieving our goal of developing a world-class heart institute in Auburn.
  • N.Y.," said Ronald Kirshner MD, Chair and Medical Director of the Auburn Heart Institute (AHI).

Four Physicians from ENT & Allergy of Delaware Are Recognized as Top Doctors by Philadelphia Magazine for 2023

Retrieved on: 
Monday, May 22, 2023
Head, University Hospitals Cleveland Medical Center, Alpha Omega Alpha, Philadelphia (magazine), COVID-19, MD, Patient, Helen, Mid-Atlantic (United States), University, Inflammation, ENT, Wake Forest University, Audiology, Allergy, Thomas Jefferson University, Hearing, Immunology, Civil and political rights, Castle Connolly Medical, Baptist Medical Center, Century, Surgeon, ChristianaCare, Publishing, Villanova, American Academy, Medical director, Parallel, Physician, Internal medicine, Otorhinolaryngology, St. Francis Hospital, Veterinary medicine, Nursing, Dentistry, Biology

NEWARK, Del., May 22, 2023 /PRNewswire/ -- ENT & Allergy of Delaware , a Parallel ENT & Allergy supported practice, proudly announces the recognition of four practice physicians as "Top Doctors" by Philadelphia Magazine for 2023 .

Key Points: 
  • NEWARK, Del., May 22, 2023 /PRNewswire/ -- ENT & Allergy of Delaware , a Parallel ENT & Allergy supported practice, proudly announces the recognition of four practice physicians as "Top Doctors" by Philadelphia Magazine for 2023 .
  • Dr. Bhatti grew up in the Philadelphia area and attended Villanova University where she graduated Magna Cum Laude in Biology.
  • She went on to Wake Forest University – Baptist Medical Center in North Carolina for her Allergy and Immunology Fellowship.
  • He is a member of the Board of Directors for Parallel ENT & Allergy, a national practice management organization for ENT and allergy practices.